... discovered an important step in the maturation pathway of ... lost at chromosome ends with every cell division. The ... of Nature . , Telomerase is viewed as ... kills cancer cells. In order to identify small molecules ...
... 25, 2008, the Obesity Institute at ... disciplines to share ideas, failures and successes, and ... to fight childhood obesity, both in the District ... Institute, Children,s National seeks to reduce childhood obesity ...
... New Rochelle, NY, December 4, 2008Researchers are taking a ... studies continue to demonstrate that inhibiting this biological route ... News ( GEN ). The pathway is involved ... it is part of the PI3/AKT/mTOR pathway, which plays ...
Other Biology News:Stowers Institute's Baumann Lab identifies key step in maturation pathway of telomerase 2Children's National convenes first childhood obesity symposium 2Children's National convenes first childhood obesity symposium 3Children's National convenes first childhood obesity symposium 4(Date:12/2/2009)... an event bringing together the leaders in technology ... and MEMS, announced the December 11th deadline for ... its 14th year, TechConnect World, in association with ... the Clean Technology and Sustainable Industries Organization (CTSI), ...
(Date:12/2/2009)... Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Emerald Dairy" or ... distributor of infant and children,s formula, milk powder and,soybean ... be featured,in the Spring issue of US Food & ... 250,000 executives in the food and beverage industry. , ...
(Date:12/2/2009)... The world is going through,extraordinary times; markets are in ... It turns out that the pharma industry has been,relatively ... a,vacation. , During the midst ... & Johnson inaugurated an R&D center in Shanghai, the ...
(Date:12/1/2009)... announced that he has joined Carolina Eyecare Physicians ... www.DrKerrySolomon.com , which was developed by Medical Consulting ... lens implant, and cataract surgery expert who has ... improving vision correction surgery. He is a ...
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6... Virus-like Particle (VLP) Vaccine Candidate Based on the 1918 ... Spanish Flu and Highly Pathogenic H5N1 Bird FluROCKVILLE, Md., ... -- Novavax, Inc. (Nasdaq: NVAX ... investigational H1N1 virus-like particle (VLP) vaccine based on the ...
... MSEDMONTON, April 14 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: ... sclerosis (MS), today announced that the independent Data Safety ... III MAESTRO-03 trial of dirucotide in patients with secondary ... that the trial continue as per the protocol. , ...
... April 14 Zenobia Therapeutics, Inc., the leader ... central nervous system, announced successful completion of the ... Pharmaceuticals, a wholly-owned subsidiary of Biogen Idec (Nasdaq: ... agreement, Syntonix gains access to Zenobia,s technology and ...
Other Biology Technology:NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 2NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 3NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 4NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 5BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals 2